Trends in Patient Characteristics and First-Year Medical Costs of Older Incident Hemodialysis Patients, 1995-2005

American Journal of Kidney Diseases

Volumn 55, Issue 3, 2010, Pages 549-557

  Mau, Lih Wen ^a   Liu, Jiannong ^a   Qiu, Yang ^a   Guo, Haifeng ^a   Ishani, Areef ^a   Arneson, Thomas J ^a   Gilbertson, David T ^a   Dunning, Stephan C ^a   Collins, Allan J ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Hemodialysis; Medicare costs; patient characteristics

Indexed keywords

HEMOGLOBIN; SERUM ALBUMIN;

AGED; ARTICLE; COMORBIDITY; COST BENEFIT ANALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; PATIENT MOBILITY; PERIPHERAL VASCULAR DISEASE; TREND STUDY;

AGE FACTORS; AGED; COHORT STUDIES; COSTS AND COST ANALYSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77049093183     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.11.014     Document Type: Article

References (25)

1. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Kramer H.J., Saranathan A., Luke A., et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17 (2006) 1453-1459
3. Ganesh S.K., Hulbert-Shearon T., Port F.K., Eagle K., and Stack A.G. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14 (2003) 415-424
4. Nakamura S., Nakata H., Yoshihara F., et al. Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J 71 (2007) 511-516
5. Orlando L.A., Owen W.F., and Matchar D.B. Relationship between nephrologist care and progression of chronic kidney disease. N C Med J 68 (2007) 9-16
6. Curtis B.M., Barrett B.J., Djurdjev O., Singer J., and Levin A. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis 50 (2007) 733-742
7. Rossert J., Fouqueray B., and Boffa J.J. Anemia management and the delay of chronic renal failure progression. J Am Soc Nephrol 14 suppl 2 (2003) S173-S177
8. Foley R.N., and Collins A.J. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 18 (2007) 2644-2648
9. Collins A.J., Foley R.N., Herzog C.A., et al. United States Renal Data System 2007 Annual Data Report Abstract [abstract]. Am J Kidney Dis 51 suppl 1 (2008) vi-vii
10. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
11. Grabe D.W. Update on clinical practice recommendations and new therapeutic modalities for treating anemia in patients with chronic kidney disease. Am J Health Syst Pharm 64 suppl 8 (2007) S8-S14
12. Hirth R.A., Roys E.C., Wheeler J.R., et al. Economic impact of case-mix adjusting the dialysis composite rate. J Am Soc Nephrol 16 (2005) 1172-1176
13. Wheeler J.R., Messana J.M., Turenne M.N., et al. Understanding the basic case-mix adjustment for the composite rate. Am J Kidney Dis 47 (2006) 666-671
14. Hirth R.A., Wolfe R.A., Wheeler J.R., et al. Is case-mix adjustment necessary for an expanded dialysis bundle?. Health Care Financ Rev 24 (2003) 77-88
15. St. Peter W.L., Kahn S.S., Ebben J.P., Pereira B.J.G., and Collins A.J. Chronic kidney disease: the distribution of health care dollars. Kidney Int 66 (2004) 313-321
16. Bradbury B.D., Fissell R.B., Albert J.M., et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2 (2007) 89-99
17. Maddux F.W., Shetty S., del Aguila M.A., Nelson M.A., and Murray B.M. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Ann Pharmacother 41 (2007) 1761-1769
18. Collins A.J., Li S., Ebben J., Ma J.Z., and Manning W. Hematocrit levels and associated Medicare expenditures. Am J Kidney Dis 36 2 (2000) 282-293
19. Rasu R.S., Crawford T., Manley H., and Balkrishnan R. Treatment and costs associated with anemic chronic kidney disease patients. Curr Med Res Opin 24 (2008) 129-137
20. Wish J.B., Nassar G.M., Schulman K., del A.M., and Provenzano R. Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease. Clin Nephrol 69 (2008) 251-259
21. Hebert P.L., Geiss L.S., Tierney E.F., Engelgau M.M., Yawn B.P., and McBean A.M. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14 (1999) 270-277
22. Stack A.G. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 41 (2003) 310-318
23. Beddhu S., Samore M.H., Roberts M.S., et al. Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 14 (2003) 2305-2312
24. Traynor J.P., Simpson K., Geddes C.C., Deighan C.J., and Fox J.G. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13 (2002) 2125-2132
25. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (2004) 324-332